Redacted SSJ 89462.pdf

This document is a Notice of Intent to Award a sole source contract to Bioanalytical Instruments, Inc. for the QuantStudio 5 Dx Real-Time PCR System. The Centers for Disease Control and Prevention (CDC) intends to award this firm fixed-price contract under the authority of FAR 13.106-1(b) and 41 U.S.C. 3304(a)(1). The CDC is currently validating the CDC Dengue PCR test on the QuantStudio 5 Dx instrument, which will soon be the only FDA-approved instrument for this test. Bioanalytical Instruments, Inc. is the exclusive local supplier and authorized service provider for Thermo Fisher instruments in Puerto Rico. The quote includes a trade-in offer for two older QuantStudio Dx instruments. Interested parties may respond within 3 days of the notice to be considered, but this is not a request for competitive proposals.